HYLG:NYE-Global X Funds - Global X Health Care Covered Call & Growth ETF (USD)

ETF | Others |

Last Closing

USD 24.7859

Change

-0.02 (-0.08)%

Market Cap

USD 2.85M

Volume

20.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.22 (+1.12%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.37 (+0.66%)

USD 32.43B
DTB DTB

+0.04 (+0.20%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

+0.35 (+1.14%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

+2.46 (+4.65%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

+0.03 (+0.06%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

+0.02 (+0.02%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

+0.90 (+1.00%)

USD 10.49B
DFUV Dimensional US Marketwide Valu..

+0.24 (+0.62%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

+0.53 (+1.02%)

USD 9.40B

ETFs Containing HYLG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.98% 47% F 50% F
Dividend Return 1.25% 64% D 57% F
Total Return 2.23% 49% F 51% F
Trailing 12 Months  
Capital Gain 1.28% 33% F 40% F
Dividend Return 6.41% 86% B+ 79% B-
Total Return 7.68% 38% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.39% 51% F 42% F
Dividend Return 1.75% 54% F 36% F
Total Return 1.37% 60% D- 33% F
Risk Return Profile  
Volatility (Standard Deviation) 4.29% 84% B 95% A
Risk Adjusted Return 40.82% 65% D 65% D
Market Capitalization 2.85M 7% C- 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.